# Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.

> **NCT00847795** · PHASE1,PHASE2 · COMPLETED · sponsor: **Renovo** · enrollment: 42 (actual)

## Conditions studied

- Cicatrix

## Interventions

- **DRUG:** Avotermin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00847795
- **Lead sponsor:** Renovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2009-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847795, "Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00847795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*